These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 494137

  • 1. Cavinton, a new cerebral vasodilator.
    Solti F.
    Ther Hung; 1979; 27(1):15-6. PubMed ID: 494137
    [No Abstract] [Full Text] [Related]

  • 2. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P, Bauer J, Ságová V.
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV, Chukhrova VA, Solov'ev OU, Nepesov RR.
    Klin Med (Mosk); 1997 Nov; 75(11):51-3. PubMed ID: 9490359
    [No Abstract] [Full Text] [Related]

  • 5. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM, Shprakh VV, Savkov VS.
    Ross Med Zh; 1992 Nov; (2):41-3. PubMed ID: 1643337
    [No Abstract] [Full Text] [Related]

  • 6. Cerebral regulation-cerebral regulators.
    Braun P.
    Ther Hung; 1980 Nov; 28(3):98-104. PubMed ID: 7221974
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Use of cavinton in neuropaediatrics].
    Studenikin VM.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004 Nov; 104(12):63-4. PubMed ID: 15847328
    [No Abstract] [Full Text] [Related]

  • 10. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM, Shprakh VV, Savkov VS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 Nov; 88(1):39-44. PubMed ID: 3364094
    [Abstract] [Full Text] [Related]

  • 11. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM, Shkrobot SI, Borak VT.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987 Nov; 87(8):1160-4. PubMed ID: 3673409
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Agents to improve cerebrovascular circulation and cerebral metabolism--vinpocetine].
    Tamaki N, Matsumoto S.
    Nihon Rinsho; 1985 Feb; 43(2):376-8. PubMed ID: 2987571
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of a series of vasoactive drugs on the compensatory adaptive processes of the brain during acute experimental cerebral venous stasis].
    Berdichevskiĭ MIa, Onopchenko NV, Dronnikova IS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987 Feb; 87(8):1178-81. PubMed ID: 3673412
    [Abstract] [Full Text] [Related]

  • 15. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E, Di Lorenzo L, De Pergola G.
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract] [Full Text] [Related]

  • 16. [The evaluation of the efficacy of antihypoxic agents lowering hemoglobin oxygen affinity in acute cerebral ischemia].
    Plotnikova TM, Plotnikov MB, Bazhenova TG.
    Biull Eksp Biol Med; 1991 Feb; 111(2):170-2. PubMed ID: 1854961
    [Abstract] [Full Text] [Related]

  • 17. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
    Man'kovsky NB, Minz AY.
    Gerontology; 1988 Feb; 34(1-2):75-81. PubMed ID: 3384341
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D, Monica C, Silvestrini C, Ceccato S, Cocchi C.
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract] [Full Text] [Related]

  • 20. Open-labeled phase III clinical trials with vinpocetine in Japan.
    Ebi O.
    Ther Hung; 1985 Apr; 33(1):41-9. PubMed ID: 3915913
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.